Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.

Anna ObermayerNorbert J TripoltPeter N PferschyHarald KojzarFaisal AzizAlexander MüllerMarkus SchauerAbderrahim OulhajFelix AbererCaren SourijHansjörg HabischTobias MadlThomas PieberBarbara Obermayer-PietschVanessa StadlbauerHarald Sourij

Published in: Diabetes care (2023)

IF is a safe and feasible dietary option to ameliorate glycemic control while reducing total daily insulin dose and body weight in insulin-treated people with type 2 diabetes.

Keyphrases

glycemic control
type diabetes
blood glucose
body weight
insulin resistance
weight loss
cardiovascular disease
physical activity
adipose tissue
metabolic syndrome
high intensity